The Myeloma Genome Project (MGP), using next-generation sequencing, defines double-hit MM as either bi-allelic TP53 inactivation or amplification of 1q21 combined with International Staging System (ISS) stage 3 [6]. Here, TP53 is linked to Miyoshi myopathy.